PortViewPortView
Medtronic logo

Medtronic (MDT) Stock Analysis

NYSEHealth CareMedical Devices

$94.14+2.28%
1-year price historyRange $73.75 – $105.35
52-week range$94.14
$73.31$106.33

What Medtronic does

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

Key metrics

Market cap
$120.50B
P/E (TTM)
17.02
EPS (TTM)
$5.53
Beta
0.57
Dividend yield
3.02%
Revenue / share
$29.33
50-day avg
$85.97
200-day avg
$89.76
52-week high
$106.33
52-week low
$73.31
CEO
Geoffrey Straub Martha

ETFs linked to MDT

Broad-market and Health Care sector ETFs an investor holding Medtronic is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how MDT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze MDT in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Medtronic?
Medtronic trades under the ticker MDT on NYSE.
Which exchange is MDT listed on?
MDT is listed on NYSE.
What sector does Medtronic operate in?
Medtronic is classified in the Health Care sector (Medical Devices industry).
How can PortView help analyze MDT in a portfolio?
PortView shows MDT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.